Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nucleosome is the fundamental structural unit of chromatin in eukaryotic cells. It consists of approximately 147 base pairs of genomic DNA wrapped in a left-handed superhelix around a histone octamer (containing two copies each of histones H2A, H2B, H3, and H4). Linker DNA between nucleosomes may associate with histone H1, forming the chromatosome. The nucleosome provides the first level of DNA compaction, regulates gene accessibility, and acts as a dynamic signaling hub for chromatin-modifying proteins and epigenetic marks. Structural dynamics of nucleosome positioning and histone modifications are essential for controlling gene expression, DNA replication, repair, recombination, and overall genome stability. Aberrations in nucleosome structure or function contribute to cancer and other diseases that involve epigenetic dysregulation. Drugs targeting the nucleosome or associated epigenetic enzymes represent an active area of therapeutic development, although safety concerns remain concerning the non-specific effects on gene expression and chromatin state.
Epigenetic enzyme modulation: Drugs alter histone post-translational modifications, affecting nucleosome structure and gene expression; Chromatin accessibility alteration: Remodelers and inhibitors can reposition or evict nucleosomes, regulating DNA accessibility; Transcriptional regulation: Changing nucleosome dynamics to up- or down-regulate specific genes
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome.